|
|
|
|
|
|
最高研发阶段临床3期 |
首次获批国家/地区- |
首次获批日期- |
/ Enrolling by invitation临床3期 A Multicenter, Randomized, Double-blinded, Active-controlled, Non-inferiority, Pivotal Clinical Trial to Evaluate the Efficacy and Safety in Pain Reduction After NPNP-001 Application in the Knee Joint of Patients with Knee Osteoarthritis
This study was designed to demonstrate non-inferiority and safety in the improvement of pain following application of NPNP-001 in patients with knee osteoarthritis.
A Randomized Open-Label Trial Comparing the Tolerability of Videx EC Capsules to Videx Tablets in Adults With HIV Infection
The purpose of this study is to compare gastrointestinal (stomach and intestines) side effects of 2 forms of Videx in HIV-infected patients.
Videx can be an effective anti-HIV treatment but many patients will not take the medication due to its side effects. Videx EC is a capsule form of the drug and may have fewer side effects. Also, patients would not have to take as many pills since patients taking Videx EC would have to take only 1 capsule per day instead of 2 tablets per day. This study will see if patients taking Videx EC have fewer side effects.
100 项与 PharmaResearch Co., Ltd. 相关的临床结果
0 项与 PharmaResearch Co., Ltd. 相关的专利(医药)
100 项与 PharmaResearch Co., Ltd. 相关的药物交易
100 项与 PharmaResearch Co., Ltd. 相关的转化医学